Drug Shortage Report for CEFAZOLIN FOR INJECTION

Last updated on 2020-01-16 History
Report ID 12782
Drug Identification Number 02452162
Brand name CEFAZOLIN FOR INJECTION
Common or Proper name Cefazolin for Injection
Company Name FRESENIUS KABI CANADA LTD
Active Ingredient(s) CEFAZOLIN
Strength(s) 10G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10g Vial
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-07-03
Actual start date
Estimated end date 2017-04-13
Actual end date 2017-06-07
Shortage status Avoided shortage
Updated date 2020-01-16
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-01-16 French Compare
v6 2020-01-16 English Compare
v5 2020-01-16 French Compare
v4 2020-01-16 English Compare
v3 2017-07-04 English Compare
v2 2017-06-14 French Compare
v1 2017-06-14 English Compare